Drug Shortage Report for MYLAN-VERAPAMIL SR
| Report ID | 188111 |
| Drug Identification Number | 02450488 |
| Brand name | MYLAN-VERAPAMIL SR |
| Common or Proper name | VERAPAMIL SR |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | VERAPAMIL HYDROCHLORIDE |
| Strength(s) | 180MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100BT |
| ATC code | C08DA |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-09-07 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-02-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2024-02-22 | French | Compare |
| v7 | 2024-02-22 | English | Compare |
| v6 | 2024-02-21 | French | Compare |
| v5 | 2024-02-21 | English | Compare |
| v4 | 2023-05-25 | French | Compare |
| v3 | 2023-05-25 | English | Compare |
| v2 | 2023-03-27 | French | Compare |
| v1 | 2023-03-27 | English | Compare |
Showing 1 to 8 of 8